Spirometry Tests Health Article

Definition

Spirometry is the measurement of airflow into and out of the lungs. The patient is given instructions on how to perform the breathing maneuvers. To perform the procedure the nose is pinched off, and the patient breathes as instructed through a mouthpiece attached to the spirometer. The three breathing maneuvers are practiced before recording the procedure, and the highest of three trials is used for evaluation of breathing. The instrument measures air flow by electronic or mechanical displacement principles and uses a microprocessor and recorder to calculate and plot air flow.

The test produces a recording of the patient's ventilation under conditions involving both normal and maximal effort. The recording, called a spirogram, shows the volume of air moved and the rate at which it is moved into and out of the lungs. There are several lung capacities that are measured by spirometry. Accurate measurement of these are dependent upon the patient performing the appropriate maneuver properly. The most common are described below:

• Vital capacity (VC): This is the amount of air in liters that is moved out of the lung during normal breathing. The patient is instructed to breathe in and out normally to full expiration for this maneuver. Vital capacity is normally about 80% of the total lung capacity. Because of the elastic nature of the lungs and surrounding thorax, a small volume of air will remain in the lungs after full exhalation. This volume is called the residual volume (RV).
• Forced vital capacity (FVC): After breathing out normally to full expiration the patient is instructed to breath in with a maximal effort and then exhale as forcefully and rapidly as possible. The FVC is the volume of air that is expelled into the spirometer following a maximum inhalation effort.
• Forced expiratory volume (FEV): At the start of the FVC maneuver, the spirometer measures volume of air that is delivered through the mouthpiece at timed intervals of 0.5, 1.0, 2.0, and 3.0 seconds. The sum of these measurements normally constitutes about 97% of the FVC measurement. The most commonly used FEV measurement is FEV-1, which is the volume of air exhaled into the mouthpiece in one second. The FEV-1 should be at least 70% of the FVC.
• Forced expiratory flow 25-75% (FEF 25-75): This is a calculation of the average flow rate over the center portion of the forced expiratory volume recording. It is determined from the time in seconds at which 25% and 75% of the vital capacity is reached. The volume of air exhaled in liters per second between these two times is the FEF 25-75. This value reflects the status of the medium and small sized airways.
• Maximal voluntary ventilation (MVV): A maneuver in which the patient breathes as deeply and as fast as possible for 15 seconds. The average airflow (liters per second) indicates the strength and endurance of the respiratory muscles.

Normal values for FVC, FEV, FEF, and MVV are dependent on the patient's age, gender and size (height).

Purpose

Spirometry is the most commonly performed pulmonary function test (PFT). The test can be performed at the bedside, in a physician's office, or pulmonary laboratory. It is often the first test performed when a problem with lung function is suspected. Spirometry may also be suggested by an abnormal x-rays, arterial blood gas analysis, or other diagnostic pulmonary test result. In March 2000, the National Lung Health Education Program recommended that regular spirometry tests be performed on persons over 45 years old who have a history of smoking. Spirometry tests are also recommended for persons having a family history of lung disease, chronic respiratory ailments, and persons of advanced age. Spirometry measures ventilation, the movement of air into and out of the lungs. The spirogram will identify two different types of abnormal ventilation patterns, obstructive and restrictive. Common causes of an obstructive pattern are cystic fibrosis, asthma, broniectasis, bronchitis, and emphysema. These conditions may be collectively referred to using the acronym CABBE. Chronic bronchitis, emphysema, and asthma result in dyspnea and ventilation deficiency, a condition known as chronic obstructive pulmonary disease (COPD). As of 2001, COPD is the fourth leading cause of death among Americans. Common causes of a restrictive pattern are pneumonia, heart disease, pregnancy, lung fibrosis, pnemothorax (collapsed lung), and pleural effusion (compression caused by chest fluid).

Obstructive and restrictive patterns can be identified on spirographs. Volume (liters) is plotted on the y-axis versus time (seconds) on the x-axis. A restrictive pattern is characterized by a normal shape showing reduced volumes for all parameters. The reduction in volumes indicates the severity of the disease. An obstructive pattern produces a spirogram with an abnormal shape. Inspiration volume is reduced. The volume of air expelled is normal, but the air flowrate is slower causing an elongated tail to the FVC.

A flow-volume loop spirogram is another way of displaying spirometry measurements. This requires a FVC maneuver followed by a forced inspiratory volume (FIV). Flow rate in liters per second is plotted on the y-axis and volume (liters) is plotted on the x-axis. The expiration phase is shown on top and the inspiration phase on the bottom. The flow-volume loop spirogram is helpful in diagnosing upper airway obstruction and can differentiate some types of restrictive patterns.

Some conditions produce specific signs on the spirogram. Irregular inspirations with rapid frequency are caused by hyperventilation associated with stress. Diffuse fibrosis of the lung causes rapid breathing of reduced volume that produces a repetitive pattern known as the penmanship sign. Serial reduction in the FVC peaks indicates trapped air inside the lung. A notch and reduced volume in the early segments of the FVC is consistent with airway collapse. A rise at the end of the expiration is associated with airway resistance.

Spirometry is used to assess lung function over time and is often used to evaluate the efficacy of bronchodilator inhalers such as albuterol. It is important that the patient not use a bronchodilator prior to the evaluation. Spirometry is performed before and after inhaling the bronchodilator. In general, a 12% or greater improvement in both FVC and FEV-1 and/or an increase in FVC by 0.2 liters is considered a significant improvement in an adult patient.